Ignite Creation Date:
2024-06-16 @ 11:51 AM
Last Modification Date:
2024-10-26 @ 3:31 PM
Study NCT ID:
NCT06453668
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2024-06-12
First Post:
2024-05-06
Brief Title:
A Study of TCD601 Siplizumab in Newly Diagnosed Adult Amyotrophic Lateral Sclerosis ALS Patients
Sponsor:
ITB-Med LLC
Organization:
ITB-Med LLC
Organization Data
Organization:
ITB-Med LLC
Class:
INDUSTRY
Study ID:
TCD601H101
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
ITB-Med LLC
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None